Search

Author/Creator Martínez, Esteban

2. Atherogenic properties of lipoproteins in HIV patients starting atazanavir/ritonavir or darunavir/ritonavir: a substudy of the ATADAR randomized study. (23rd December 2014)

Authors:
Saumoy, Maria; Ordóñez-Llanos, Jordi; Martínez, Esteban; Ferrer, Elena; Domingo, Pere; Ribera, Esteban; Negredo, Eugenia; Curto, Jordi; Sánchez-Quesada, José Luis; Di Yacovo, Silvana; González-Cordón, Ana; Podzamczer, Daniel
Journal:
Journal of antimicrobial chemotherapy
Issue:
Volume 70:Number 4(2015:Apr.)
Page Start:
1130
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Atherogenicity of low-density lipoproteins after switching from a protease inhibitor to dolutegravir: a substudy of the NEAT022 study. (13th April 2022)

Authors:
Saumoy, Maria; Sánchez-Quesada, Jose Luís; Assoumou, Lambert; Gatell, José Maria; González-Cordón, Ana; Guaraldi, Giovanni; Domingo, Pere; Giacomelli, Andrea; Connault, Jérôme; Katlama, Christine; Masiá, Mar; Ordónez-Llanos, Jordi; Pozniak, Anton; Martínez, Esteban; Podzamczer, Daniel
Journal:
Journal of antimicrobial chemotherapy
Issue:
Volume 77:Number 7(2022)
Page Start:
1980
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain. (November 2020)

Authors:
Berenguer, Juan; Ryan, Pablo; Rodríguez-Baño, Jesús; Jarrín, Inmaculada; Carratalà, Jordi; Pachón, Jerónimo; Yllescas, María; Arriba, José Ramón; Aznar Muñoz, Esther; Gil Divasson, Pedro; González Muñiz, Patricia; Muñoz Aguirre, Clara; López, Juan Carlos; Ramírez-Schacke, Margarita; Gutiérrez, Is...
Journal:
Clinical microbiology and infection
Issue:
Volume 26:Number 11(2020)
Page Start:
1525
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Daily tenofovir disoproxil fumarate/emtricitabine and hydroxychloroquine for pre-exposure prophylaxis of COVID-19: a double-blind placebo-controlled randomized trial in healthcare workers. (January 2023)

Authors:
Polo, Rosa; García-Albéniz, Xabier; Terán, Carolina; Morales, Miguel; Rial-Crestelo, David; Garcinuño, M. Angeles; García del Toro, Miguel; Hita, César; Gómez-Sirvent, Juan Luis; Buzón, Luis; Díaz de Santiago, Alberto; Arellano, Jose Pérez; Sanz, Jesus; Bachiller, Pablo; Alfaro, Elisa Martínez; D...
Journal:
Clinical microbiology and infection
Issue:
Volume 29:Number 1(2023)
Page Start:
85
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Effectiveness of boosted darunavir plus rilpivirine in patients with long-lasting HIV-1 infection: DARIL study. (5th March 2020)

Authors:
Navarro, Jordi; González-Cordón, Ana; Casado, José Luís; Bernardino, Jose I; Domingo, Pere; Portilla, Joaquin; Llibre, Josep Maria; Colomer, Joan; Rial-Crestelo, David; Vizcarra, Pilar; Curran, Adrià; Martínez, Esteban; Ribera, Esteban
Journal:
Journal of antimicrobial chemotherapy
Issue:
Volume 75:Number 7(2020)
Page Start:
1955
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Effects of Hepatitis C Virus (HCV) Eradication on Bone Mineral Density in Human Immunodeficiency Virus/HCV-Coinfected Patients. (15th September 2020)

Authors:
Carrero, Ana; Berenguer, Juan; Hontañón, Víctor; Guardiola, Josep M; Navarro, Jordi; von Wichmann, Miguel A; Téllez, María J; Quereda, Carmen; Santos, Ignacio; Sanz, José; Galindo, María J; Hernández-Quero, José; Jiménez-Sousa, María A; Pérez-Latorre, Leire; Bellón, José M; Resino, Salvador; Este...
Journal:
Clinical infectious diseases
Issue:
Volume 73:Number 7(2021)
Page Start:
e2026
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Efficacy and safety of switching to dolutegravir plus lamivudine versus continuing triple antiretroviral therapy in virologically suppressed adults with HIV at 48 weeks (DOLAM): a randomised non-inferiority trial. Issue 8 (August 2021)

Authors:
Rojas, Jhon; de Lazzari, Elisa; Negredo, Eugenia; Domingo, Pere; Tiraboschi, Juan; Ribera, Esteve; Abdulghani, Nadia; Puig, Jordi; Mateo, Maria G; Podzamczer, Daniel; Gutierrez, Maria M; Paredes, Roger; Clotet, Bonaventura; Gatell, Jose M; Blanco, Jose L; Martínez, Esteban
Journal:
Lancet
Issue:
Volume 8:Issue 8(2021)
Page Start:
e463
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗